PHG
Koninklijke Philips N.V.26.53
+0.07+0.27%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Q&A adds execution color, reaffirms guide
Q&A reinforced Philips' strong Q4 beat and 2026 guidance of 3-4.5% sales growth with 12.5-13% EBITDA margins, adding color on D&T's sustained order intake momentum—double-digit IGT, accelerating MR/ultrasound—but slower sales conversion due to longer cycles versus Connected Care. Gross margins expand via innovation mix and productivity despite annualizing EUR 250-300M tariffs; PH's 23% Q4 margin drove by premium OneBlade/Sonicare, share gains, no stocking pull-forward. China stabilizes cautiously, health systems tenders unpredictable; Section 232 tariffs neutral at worst. Orders strong, sales lag slightly. Management exuded confidence, deferring midterm to CMD.
Key Stats
Market Cap
25.23BP/E (TTM)
139.63Basic EPS (TTM)
0.19Dividend Yield
0.03%BSX
Boston Scientific Corporation
92.95+0.76
CNMD
CONMED Corporation
39.20-1.12
DYNT
Dynatronics Corp.
0.04+0.00
GEHC
GE HealthCare Technologies Inc.
82.25-2.20
LIVN
LivaNova PLC
63.08+0.02
MDT
Medtronic plc.
97.72-0.85
NMTC
NeuroOne Medical Technologies C
0.71+0.05
RMD
ResMed Inc.
247.34-5.73
SNWV
SANUWAVE Health, Inc.
31.46-0.18
SYK
Stryker Corporation
351.69-3.62